Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 803 results for "btig"

Video: Tide of media goes out, ESPN not safe either: Analyst
NBCNews.com

Video: Tide of media goes out, ESPN not safe either: Analyst

CNBC | August 20, 2015 Rich Greenfield, BTIG media analyst, explains why Disney is not safe from cord-cutting, and the biggest challenges for niche basic cable networks. NBCNews.com, 1 week ago
Video: Concerns over consumers: Pro NBCNews.com, 4 weeks ago
Forex Magnates

BTIG Taps Tim Cunningham as Director of FX Sales

BTIG has strengthened its foreign exchange (FX) unit with the addition of Tim Cunningham as its Director of FX Sales, according to information made public on his Linkedin profile. In his new role as the Director of FX Sales, Mr. Cunningham will ...
 Forex Magnates2 weeks ago
CNBC

BTIG: 'Concerned' About Traditional Media Companies, Netflix Still Appealing

The advertising dollars flowing to Internet seems to be taking a major toll on traditional media companies whose mainstay is advertising revenue. BTIG analyst Rich Greenfield was on CNBC Monday to discuss how the decline in TV advertising and the ...
 Benzinga.com4 weeks ago Tough call with cable OTT plans  CNBC3 weeks ago

Video: Apple dips lower

CNBC | August 03, 2015 Walter Piecyk, BTIG, weighs in on a stalled Apple stock, and what product can really help the company take off. He says the U.S. remains a driving force of Apple's earnings.
 NBCNews.com4 weeks ago Apple, in correction territory, can recover: BTIG  Yahoo! 7 Finance4 weeks ago
American Banking News

Medtronic PLC's Buy Rating Reiterated at BTIG Research (MDT)

Medtronic PLC (NYSE:MDT)s stock had its buy rating restated by investment analysts at BTIG Research in a note issued to investors on Tuesday, AnalystRatings.Net reports. They presently have a $89.00 price target on the medical technology company's ...
 American Banking News1 day ago BTIG Research Reaffirms Abbott Laboratories (NYSE:ABT) as buy  Octafinance3 days ago BTIG Research Reaffirms Buy Rating for Abbott Laboratories (ABT)  American Banking News3 days ago Cheniere Energy (NYSE:LNG) Investors: BTIG Research Maintains buy Rating, Sees $100.00/Share  Octafinance4 days ago
[x]  
Octafinance

Vital Therapies (NYSE:VTL) Stock buy Rating Kept at BTIG Research; The Target Price Given is $7.00

Vital Therapies (NYSE:VTL) Rating Restated New York: In a note issued to clients and investors on Friday, 9 January, BTIG Research reiterated their buy rating on shares of Vital Therapies (NYSE:VTL). They currently have a $7.00 target price on the ...
 Octafinance21 hours ago Synergy Pharmaceuticals Now Covered by Analysts at BTIG Research (SGYP)  WKRB News1 week ago Why BTIG Research Started Coverage On Synergy Pharmaceuticals (NASDAQ:SGYP) Stock With Buy Rating  Octafinance1 week ago BTIG Research has $5.00 PT on Synthetic Biologics (AMEX:SYN) after Started Coverage  Octafinance1 week ago
[x]  
Octafinance

BTIG Research Keeps $28.00 Target Price On Green Dot (NASDAQ:GDOT), Keeps buy Rating

Green Dot (NASDAQ:GDOT) Rating Kept The financial company have set target price of $28.00 on Green Dot (NASDAQ:GDOT) shares. This is 61.29% from the last stock close price. In an analyst report issued to investors and clients on Thursday, 20 ...
 Octafinance1 week ago Green Dot Receives $21.36 Average Price Target from Brokerages (NASDAQ:GDOT)  WKRB News5 days ago
Octafinance

Accuray (NASDAQ:ARAY) Investors: BTIG Research Reiterates neutral Rating

Accuray (NASDAQ:ARAY) Rating Kept Today, BTIG Research reconfirmed their neutral rating on Accuray (NASDAQ:ARAY)'s stock in an analyst note issued to clients and investors. NASDAQ:ARAY is right now trading 12.67% higher at $6.58 as of 01:07 New ...
 Octafinance1 week ago BTIG Research Reaffirmed Cyberonics (NASDAQ:CYBX) as neutral  Octafinance1 week ago
SleekMoney

Accelerate Diagnostics Receives Hold Rating from BTIG Research (AXDX)

BTIG Research reissued their hold rating on shares of Accelerate Diagnostics (NASDAQ:AXDX) in a report released on Sunday morning, ARN reports. Accelerate Diagnostics ( NASDAQ:AXDX ) opened at 19.22 on Friday. Accelerate Diagnostics has a 52 week ...
 SleekMoney2 weeks ago Accelerate Diagnostics Earns Hold Rating from BTIG Research (AXDX)  Mideast Time1 week ago
American Banking News

Analysts Updated EPS Estimates for August, 14th (A, AAVL, ARMK, AXS, BTA, CBK, CC, CHS, CIT, CNXC)

Agilent Technologies (NYSE:A) had its buy rating reiterated by analysts at BTIG Research. They currently have a $52.00 price target on the stock. Avalanche Biotechnologies (NASDAQ:AAVL) had its overweight rating reissued by analysts at Piper ...
 American Banking News2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - btig
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less